The SEMA application (SEMA App) is for people with type 2 diabetes mellitus for whom the medicine Ozempic® Semaglutide has been prescribed by their doctor. The app provides helpful tips and practical tools to help you get started and stay motivated during the early stages of treatment.
Use SEMA App to:
• Find the most convenient time to administer your medication and create weekly reminders
• Plan appointments with your treating physician or other healthcare professional
• Obtain educational resources to solve some doubts about the treatment with your medicine.
• Track, analyze, download and share your treatment data with your medicine
• Watch a video that will show you how to use your device correctly
• Download the SEMA App today to get started.
If you need to report an adverse event related to a Novo Nordisk® product, please contact us at the following address: [email protected] or at the following telephone numbers: NovoDía patient program telephone numbers: Panama (507 ) 833-7427; Costa Rica (506) 4001-8475; Guatemala (502) 2278-6755; Honduras (504) 2263-2888; El Salvador (503) 21130899; Dominican Republic / Santiago 1 (829) 947-6550; Dominican Republic / Santo Domingo 1 (829) 946-0085
Educational material for patients. Ozempic®, NovoDía® and Novo Nordisk® are registered trademarks owned by Novo Nordisk. ACE.
Material reviewed and approved by the Novo Nordisk Medical and Legal Affairs Directorate. In case you wish to report an adverse event, write to the following email: [email protected]